When clinicopathological parameters and IHC subtypes were analyzed against survival in a univariable Cox hazard model, tumor stage (pT and N), lymphovascular invasion, pathologic grade, loss of GATA3 immunoreactivity, and loss of CK5/6 immunoreactivity were significantly associated with poorer survival outcomes. This evidence concerns the gene GATA3 and neoplasm.